concept

SS

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about SS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

162Connections
30Hypotheses
30Analyses
1Outgoing
50Incoming

Summary

SS is a concept in neurodegeneration research. Key relationships include: implicated in, contributes to, causes. Connected to 162 entities in the SciDEX knowledge graph.

View on Wiki →

💡 Concept Info
NameSS
Key Genes/ProteinsMAP1B, MAP2, MAP6, GLUT4, PPAR, RAB7A
Related PathwaysIFN_PATHWAY, PI3K_AKT_MTOR
Linked Hypotheses94 hypotheses

Wiki Pages (20)

Knowledge base pages for this entity

cbs-psp-daily-action-plan

therapeutic · 30834 words

Progressive Supranuclear Palsy (PSP)

disease · 12907 words

primary-progressive-aphasia

disease · 7088 words

Section 148: Advanced Nutritional Biochemistry in CBS/PSP

therapeutic · 6350 words

NTF4 Protein

protein · 5111 words

Pathway Diagram

graph TD
    SS["SS"]
    SS -->|"causes"| SALIVARY_GLAND["SALIVARY_GLAND"]
    T_CELL["T_CELL"] -->|"contributes to"| SS
    B_CELL["B_CELL"] -->|"contributes to"| SS
    IFN_PATHWAY["IFN_PATHWAY"] -->|"contributes to"| SS
    PI3K_AKT_MTOR["PI3K_AKT_MTOR"] -->|"contributes to"| SS
    MAP1B["MAP1B"] -->|"implicated in"| SS
    MAP2["MAP2"] -->|"implicated in"| SS
    MAP6["MAP6"] -->|"implicated in"| SS
    GLUT4["GLUT4"] -->|"implicated in"| SS
    PPAR["PPAR"] -->|"implicated in"| SS
    RAB7A["RAB7A"] -->|"implicated in"| SS

Outgoing (1)

TargetRelationTypeStr
SALIVARY_GLANDcausescell_type0.72

Incoming (161)

SourceRelationTypeStr
T_CELLcontributes_tocell_type0.64
B_CELLcontributes_tocell_type0.64
IFN_PATHWAYcontributes_topathway0.64
PI3K_AKT_MTORcontributes_topathway0.64
MAP1Bimplicated_ingene0.50

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Closed-loop tACS targeting EC-II SST interneurons to block t 0.697 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop focused ultrasound targeting EC-II SST interneur 0.697 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop tACS targeting EC-II PV interneurons to suppress 0.670 Alzheimer's disease Circuit-level neural dynamics in neurode
Stathmin-2 Splice Switching to Prevent Axonal Degeneration A 0.664 neurodegeneration RNA binding protein dysregulation across
ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro 0.662 Alzheimer's Disease Cell type vulnerability in Alzheimers Di
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen 0.639 neurodegeneration Gene expression changes in aging mouse b
Closed-loop transcranial focused ultrasound targeting EC-II 0.633 Alzheimer's disease Circuit-level neural dynamics in neurode
CYP46A1 Overexpression Gene Therapy 0.631 neurodegeneration Lipid raft composition changes in synapt
Closed-loop tACS targeting entorhinal cortex layer II SST in 0.625 Alzheimer's disease Circuit-level neural dynamics in neurode
Alpha-gamma cross-frequency coupling enhancement to restore 0.621 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound targeting EC-II 0.612 Alzheimer's disease Circuit-level neural dynamics in neurode
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene 0.612 neurodegeneration Gene expression changes in aging mouse b
TREM2-ASM Crosstalk in Microglial Lysosomal Senescence 0.612 neurodegeneration Gene expression changes in aging mouse b
TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener 0.607 neurodegeneration Gene expression changes in aging mouse b
Multi-Modal Stress Response Harmonization 0.601 neurodegeneration Digital biomarkers and AI-driven early d
Metabolic NAD+ Salvage Pathway Enhancement Through NAMPT Ove 0.592 neurodegeneration Epigenetic reprogramming in aging neuron
TREM2-CSF1R Cross-Talk in Microglial Metabolic Reprogramming 0.589 neurodegeneration Gene expression changes in aging mouse b
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene 0.585 neurodegeneration Gene expression changes in aging mouse b
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene 0.580 neurodegeneration Gene expression changes in aging mouse b
Interneuron SYNGAP1 Deficiency Disrupts Cortical Circuit Ass 0.576 neurodevelopment How does SYNGAP1, a 'synaptic' protein,
ER Stress Reduction as Adjunctive Therapy to Support Autopha 0.566 neurodegeneration Why does iron chelation therapy worsen o
Complement C1q Suppression as Mechanism Linking Exercise Pla 0.560 neurodegeneration What are the specific circulating factor
Chromatin Accessibility Restoration via BRD4 Modulation 0.559 neurodegeneration Epigenetic reprogramming in aging neuron
Optogenetic restoration of hippocampal gamma oscillations vi 0.554 Alzheimer's disease Circuit-level neural dynamics in neurode
Real-time gamma-guided transcranial focused ultrasound targe 0.538 Alzheimer's disease Circuit-level neural dynamics in neurode
Dissociating SCFA's Dual Signaling Through GPR43/GPR41 Biase 0.525 neurodegeneration Do SCFAs directly modulate α-synuclein a
Heterogeneous astrocyte activation states differentially imp 0.523 Alzheimer's disease SEA-AD Single-Cell Analysis: Cell-Type V
TBK1 Loss-of-Function Amplifies C1q-Mediated Synapse Elimina 0.520 neurodegeneration How do the seven novel ALS genes functio
Matrix Stiffness Normalization via Targeted Lysyl Oxidase In 0.515 neurodegeneration Perivascular spaces and glymphatic clear
40 Hz Gamma Entrainment Gates ACSL4-Mediated Ferroptotic Pri 0.515 Alzheimer's Disease Cell type vulnerability in Alzheimers Di

Mentioning Analyses (30)

Scientific analyses that reference this entity

How do sphingomyelin/ceramide ratios specifically regulate BACE1 clustering and

neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.596

What are the specific molecular determinants that govern tau strain selection du

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.636

What are the cell-type-specific transcriptomic signatures of vulnerability in SE

neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.576

How do synthetic EVs achieve brain-specific targeting while avoiding reticuloend

drug delivery | 2026-04-15 | 0 hypotheses

Are age-related static epigenetic patterns pathogenic or protective compensatory

epigenetics | 2026-04-15 | 0 hypotheses

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1. [PMID:37384704] Zhang T, Xu D, Trefts E, Lv M, Inuzuka H Science 2023 1
TREM2, microglia, and Alzheimer's disease. [PMID:33516818] Qin Q, Teng Z, Liu C, Li Q, Yin Y, Tang Mech Ageing Dev 2021 1
Complement and microglia mediate early synapse loss in Alzheimer mouse models. [PMID:27033548] Hong S, Beja-Glasser VF, Nfonoyim BM, Fr Science 2016 1
Potential Biological Processes Related to Brain SLC13A5 Across the Lifespan: Wei [PMID:41750164] Ferreira BK, Schuck PF, Ferreira GC, Fre Brain sciences 2026 0
How cytochrome P450 enzymes in humans are involved in Parkinson's disease: a lit [PMID:41730497] Ren B, Yan H, Han C, Sun S, Wang D, Xu Y Neuroscience 2026 0
Dysregulated Cholesterol Clearance via CYP46A1 Contributes to Cerebellar Sterol [PMID:41828569] Tapia PJ, Rivera BI, Espinoza CS, Stolze International journal of molec 2026 0
Efavirenz treatment improves retinal vaso-obliteration and pathological neovascu [PMID:41810243] Bailey B, Rudd Zhong Manis J, Seth G, Ra Frontiers in medicine 2026 0
Radiosynthesis and Evaluation of 18F‑Labeled Deuterated Radioligand for Positron [PMID:41704371] Li Y, Song Z, Shi H, Zhao T, Chen J, Zho ACS medicinal chemistry letter 2026 0
FAK/SRC-JNK axis promotes ferroptosis via upregulating ACSL4 expression. [PMID:41862445] Qin J, Ma S, Wang J, Huang S, Luan J, He Cell death & disease 2026 0
Quercetin attenuates ox-LDL-induced endothelial injury by regulating ferroptosis [PMID:41902795] Gao C, Liu B, Zhang R, Tian J, Xin H Toxicology mechanisms and meth 2026 0
NEDD8 promotes the ferritinophagy and ferroptosis of neurons in ischemic stroke [PMID:41662890] Rao W, Huang Y, Li J, Chen Q, Sun J et a J Stroke Cerebrovasc Dis 2026 0
Inhibition of Ferroptosis in Prostatitis Model by Low Intensity Extracorporeal S [PMID:41714892] Lin D, Li K, Kuang W, Chen Z, Zhang M World J Mens Health 2026 0
Deciphering sorafenib resistance in hepatocellular carcinoma via ferroptotic mec [PMID:41763496] Che L, Zhu L, Zhou L, Zhou Y Biochim Biophys Acta Rev Cance 2026 0
B4GALT1 deficiency attenuates steatohepatitis by regulating the PPARγ/ACSL4 axis [PMID:41860570] Chien Y, Xia R, Zhou D, Ai Y, Wu L et al Hepatol Commun 2026 0
[The Chinese medicine Gandouling attenuates brain injury in hepatolenticular deg [PMID:41946579] Wu K, Wang N, Zhao D, Wei W, Zhang W et Zhejiang Da Xue Xue Bao Yi Xue 2026 0
Unraveling the impact of risk factors on the ferroptosis-Alzheimer's disease lin [PMID:41498558] Singh P, Rath SL Journal of Alzheimer's disease 2026 0
Resveratrol Alleviates Intervertebral Disc Degeneration by Targeting NCOA4-Media [PMID:41873334] Song C, Wu X, Chen C, Shen B, He Y, Liu Drug design, development and t 2026 0
Pan-PPAR agonist bezafibrate alleviates psoriasis by suppressing LCN2-dependent [PMID:41662914] ["Xin R", "Zhang J", "Zhang Y", "Dai M", Free radical biology & medicin 2026 0
Acteoside alleviates sepsis-induced acute lung injury by activating the Nrf2 pat [PMID:41895086] Wang Y, Zhang W, Zhang M, Zhu Y, Wang W, Tissue & cell 2026 0
Ferroptosis and microglial polarization in retinal vein occlusion: pathological [PMID:41924362] Xu J, Sun M, Wang C, Ju P, Guan XD, Xie International journal of ophth 2026 0